vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and Industrial Logistics Properties Trust (ILPT). Click either name above to swap in a different company.
AVANOS MEDICAL, INC. is the larger business by last-quarter revenue ($180.9M vs $113.9M, roughly 1.6× Industrial Logistics Properties Trust). AVANOS MEDICAL, INC. runs the higher net margin — -0.7% vs -1.6%, a 0.8% gap on every dollar of revenue. On growth, Industrial Logistics Properties Trust posted the faster year-over-year revenue change (3.1% vs 0.7%). Industrial Logistics Properties Trust produced more free cash flow last quarter ($42.0M vs $21.3M). Over the past eight quarters, AVANOS MEDICAL, INC.'s revenue compounded faster (4.4% CAGR vs 0.7%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
Industrial Logistics Properties Trust is a real estate investment trust that owns and operates a portfolio of industrial and logistics real estate assets primarily across the United States. Its holdings include distribution centers, warehouses, and last-mile delivery properties, serving e-commerce, retail, manufacturing and supply chain operators to meet their storage and logistics operation needs.
AVNS vs ILPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $113.9M |
| Net Profit | $-1.3M | $-1.8M |
| Gross Margin | 47.5% | — |
| Operating Margin | 1.4% | -22.1% |
| Net Margin | -0.7% | -1.6% |
| Revenue YoY | 0.7% | 3.1% |
| Net Profit YoY | 99.7% | 92.6% |
| EPS (diluted) | $-0.02 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $113.9M | ||
| Q3 25 | $177.8M | $110.9M | ||
| Q2 25 | $175.0M | $112.1M | ||
| Q1 25 | $167.5M | $111.9M | ||
| Q4 24 | $179.6M | $110.5M | ||
| Q3 24 | $170.4M | $108.9M | ||
| Q2 24 | $171.7M | $110.6M | ||
| Q1 24 | $166.1M | $112.2M |
| Q4 25 | $-1.3M | $-1.8M | ||
| Q3 25 | $-1.4M | $-21.6M | ||
| Q2 25 | $-76.8M | $-21.3M | ||
| Q1 25 | $6.6M | $-21.5M | ||
| Q4 24 | $-397.3M | $-24.1M | ||
| Q3 24 | $4.3M | $-25.0M | ||
| Q2 24 | $1.8M | $-23.2M | ||
| Q1 24 | $-900.0K | $-23.4M |
| Q4 25 | 47.5% | — | ||
| Q3 25 | 48.4% | — | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.6% | — | ||
| Q4 24 | 54.6% | — | ||
| Q3 24 | 54.5% | — | ||
| Q2 24 | 55.7% | — | ||
| Q1 24 | 57.1% | — |
| Q4 25 | 1.4% | -22.1% | ||
| Q3 25 | 0.1% | -29.4% | ||
| Q2 25 | -42.6% | -30.8% | ||
| Q1 25 | 6.1% | -26.9% | ||
| Q4 24 | -233.0% | -31.1% | ||
| Q3 24 | 7.0% | -33.5% | ||
| Q2 24 | 3.7% | -32.4% | ||
| Q1 24 | 2.4% | -31.7% |
| Q4 25 | -0.7% | -1.6% | ||
| Q3 25 | -0.8% | -19.4% | ||
| Q2 25 | -43.9% | -19.0% | ||
| Q1 25 | 3.9% | -19.2% | ||
| Q4 24 | -221.2% | -21.8% | ||
| Q3 24 | 2.5% | -22.9% | ||
| Q2 24 | 1.0% | -20.9% | ||
| Q1 24 | -0.5% | -20.9% |
| Q4 25 | $-0.02 | $-0.02 | ||
| Q3 25 | $-0.03 | $-0.33 | ||
| Q2 25 | $-1.66 | $-0.32 | ||
| Q1 25 | $0.14 | $-0.33 | ||
| Q4 24 | $-8.64 | $-0.37 | ||
| Q3 24 | $0.09 | $-0.38 | ||
| Q2 24 | $0.04 | $-0.35 | ||
| Q1 24 | $-0.02 | $-0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $94.8M |
| Total DebtLower is stronger | $90.3M | $4.2B |
| Stockholders' EquityBook value | $778.2M | $489.7M |
| Total Assets | $1.1B | $5.2B |
| Debt / EquityLower = less leverage | 0.12× | 8.56× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | $94.8M | ||
| Q3 25 | $70.5M | $83.2M | ||
| Q2 25 | $90.3M | $58.6M | ||
| Q1 25 | $97.0M | $108.0M | ||
| Q4 24 | $107.7M | $131.7M | ||
| Q3 24 | $89.0M | $153.9M | ||
| Q2 24 | $92.2M | $146.2M | ||
| Q1 24 | $75.8M | $128.4M |
| Q4 25 | $90.3M | $4.2B | ||
| Q3 25 | $93.4M | $4.2B | ||
| Q2 25 | $95.7M | $4.2B | ||
| Q1 25 | $98.0M | $4.3B | ||
| Q4 24 | $125.3M | $4.3B | ||
| Q3 24 | $152.6M | $4.3B | ||
| Q2 24 | $164.9M | $4.3B | ||
| Q1 24 | $167.2M | $4.3B |
| Q4 25 | $778.2M | $489.7M | ||
| Q3 25 | $778.0M | $494.1M | ||
| Q2 25 | $776.3M | $519.1M | ||
| Q1 25 | $839.4M | $539.5M | ||
| Q4 24 | $828.5M | $562.0M | ||
| Q3 24 | $1.2B | $585.9M | ||
| Q2 24 | $1.2B | $618.3M | ||
| Q1 24 | $1.2B | $643.2M |
| Q4 25 | $1.1B | $5.2B | ||
| Q3 25 | $1.1B | $5.2B | ||
| Q2 25 | $1.0B | $5.2B | ||
| Q1 25 | $1.1B | $5.4B | ||
| Q4 24 | $1.2B | $5.4B | ||
| Q3 24 | $1.7B | $5.5B | ||
| Q2 24 | $1.7B | $5.5B | ||
| Q1 24 | $1.7B | $5.5B |
| Q4 25 | 0.12× | 8.56× | ||
| Q3 25 | 0.12× | 8.49× | ||
| Q2 25 | 0.12× | 8.09× | ||
| Q1 25 | 0.12× | 7.96× | ||
| Q4 24 | 0.15× | 7.65× | ||
| Q3 24 | 0.12× | 7.35× | ||
| Q2 24 | 0.13× | 6.96× | ||
| Q1 24 | 0.14× | 6.70× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $60.7M |
| Free Cash FlowOCF − Capex | $21.3M | $42.0M |
| FCF MarginFCF / Revenue | 11.8% | 36.9% |
| Capex IntensityCapex / Revenue | 3.8% | 16.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $79.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $60.7M | ||
| Q3 25 | $14.0M | $22.7M | ||
| Q2 25 | $6.8M | $18.4M | ||
| Q1 25 | $25.7M | $11.4M | ||
| Q4 24 | $57.9M | $2.0M | ||
| Q3 24 | $23.0M | $-3.4M | ||
| Q2 24 | $27.8M | $10.8M | ||
| Q1 24 | $-8.0M | $8.0M |
| Q4 25 | $21.3M | $42.0M | ||
| Q3 25 | $7.0M | $17.6M | ||
| Q2 25 | $-4.2M | $15.2M | ||
| Q1 25 | $19.0M | $5.0M | ||
| Q4 24 | $53.1M | $-3.7M | ||
| Q3 24 | $20.0M | $-5.9M | ||
| Q2 24 | $21.9M | $9.4M | ||
| Q1 24 | $-12.1M | $5.9M |
| Q4 25 | 11.8% | 36.9% | ||
| Q3 25 | 3.9% | 15.9% | ||
| Q2 25 | -2.4% | 13.5% | ||
| Q1 25 | 11.3% | 4.5% | ||
| Q4 24 | 29.6% | -3.4% | ||
| Q3 24 | 11.7% | -5.5% | ||
| Q2 24 | 12.8% | 8.5% | ||
| Q1 24 | -7.3% | 5.2% |
| Q4 25 | 3.8% | 16.4% | ||
| Q3 25 | 3.9% | 4.6% | ||
| Q2 25 | 6.3% | 2.9% | ||
| Q1 25 | 4.0% | 5.7% | ||
| Q4 24 | 2.7% | 5.2% | ||
| Q3 24 | 1.8% | 2.3% | ||
| Q2 24 | 3.4% | 1.3% | ||
| Q1 24 | 2.5% | 1.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.89× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.35× | — | ||
| Q2 24 | 15.44× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
ILPT
Segment breakdown not available.
